Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program. Research & Clinical Trial Webinars,Webinars 4 years ago You may also like 59:32 Webinar: Wave Life Sciences – Update on FORWARD-53 Study of WVE-N531 1 week ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 1:00:09 Webinar: Avidity Biosciences – Topline Data from EXPLORE44® Clinical Trial 2 weeks ago Research & Clinical Trial Webinars,Webinars AOC 1044,avidity biosciences,del-zota 47:43 Webinar: Capricor Therapeutics – Update on Deramiocel for Cardiomyopathy in Patients with Duchenne 1 month ago Research & Clinical Trial Webinars,Webinars cap-1002,capricor,cardiac,deramiocel 02:15:11 PPMD’s Duchenne Early Intervention Symposium 1 month ago Webinars newborn screening 01:08:05 Webinar: Solid Biosciences – Update on Gene Therapy Candidate SGT-003 2 months ago Research & Clinical Trial Webinars,Webinars gene therapy,sgt-003,solid biosciences 58:14 Webinar: Sevasemten – CANYON Trial Topline Results 4 months ago Research & Clinical Trial Webinars,Webinars edg-5506,edgewise 1:01:40 Webinar: RGX-202 – AFFINITY DUCHENNE Pivotal Program and Functional Data 5 months ago Research & Clinical Trial Webinars,Webinars gene therapy,RGX-202 51:49 Webinar: INSPIRE DUCHENNE Clinical Trial Update and Study Expansion 5 months ago Research & Clinical Trial Webinars,Webinars sgt-003,solid biosciences 123…26»Page 1 of 26